Nuvigil 50; 150 & 250 mg Tablets.
PDF Leaflet Revision Date: 15 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy.
Dosage (summary)
150 mg or 250 mg once daily in the morning.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- CYP3A4 inducers/inhibitors
- CYP2C19 substrates
- Steroidal contraceptives
Contraindications
- Hypersensitivity to armodafinil
- Pregnancy
- Uncontrolled hypertension
Common side effects
- Headache
- Nausea
- Dizziness
- Insomnia
Counselling Points
- Take on an empty stomach for faster onset.
- Monitor for signs of rash or hypersensitivity.
- Avoid driving until effects are known.
Serious warnings
- Serious rash including Stevens-Johnson Syndrome
- Psychiatric symptoms
- Potential for abuse and dependence
Important Disclaimer
The Nuvigil 50; 150 & 250 mg Tablets. professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
